Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd clinical trials

Explore recruiting patients symptomatic with pulmonary hypertension associated with left ventricular systolic dysfunction ph slvd clinical trials.

Also recruiting in Europe

Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(14308) Randomized, double-blind, placebo-controlled, parallel-group, multi-center study to evaluate the hemodynamic effects of Riociguat (BAY 63-2521) as well as safety and kinetics in patients with pulmonary hypertension associated with left ventricular systolic dysfunction.

Italy, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd trials by city

Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Toronto Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Vancouver Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Montreal Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Calgary Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Edmonton Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Ottawa Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Winnipeg Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Quebec City Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Hamilton Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Kitchener Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in London Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Halifax Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in New York Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Los Angeles Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Chicago Patients Symptomatic With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Ph Slvd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease